Fairchem Organics Limited — Investor Meet, 21-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance**: For Q2 FY’25, Fairchem Organics reported revenue from operations of ₹139 crores, reflecting a 9% decline year-on-year. The EBITDA was ₹9 crores, down 48% year-on-year, yielding margins of 6.28%. The net profit also plummeted by 61% to ₹4 crores, with PAT margins at 2.89%. For H1 FY’25, revenues dropped 3% to ₹304 crores, while EBITDA grew by 7% to ₹31 crores, resulting in a margin of 10.05%. Net profit for this period grew by 9% to ₹18 crores, with PAT margins at 5.9%. A significant drop in sales volume and value occurred, primarily due to weak demand from the paint sector in August and September.

2. **Future Outlook and Growth Drivers**: Management emphasized optimism about the value-added product, Isostearic acid, even in light of current challenges. They maintained current volume growth guidance of 10-15% for FY’25, though achieving it may be challenging given present circumstances. The company is strategically positioned to increase Isostearic acid production as approvals from customers are anticipated in the coming quarters.

3. **Order Book and Operational Updates**: Sales volumes for Q2 were reported at over 14,000 tons, with linoleic and dimer acid making up approximately 68-69% of total sales. The company is navigating higher raw material costs due to an increased custom duty on certain oils while keeping certain prices stable to retain market share.

4. **Analyst Q&A Insights (Detailed)**:

- **Revenue and Profitability**: Analysts sought clarification on margins and revenue projections linked to rising costs and competitive pressures, particularly from low-priced imports.

- **Market Position and Competitive Landscape**: Discussions highlighted the impact of price elasticity in the dimer acid market influenced by stable import duties from competitors, notably China.

- **Operational Challenges or Risks**: Management acknowledged risks related to demand from the paint sector and a potential further deterioration in margins should custom duties persist.

- **Capex and Capital Allocation**: Analysts expressed concerns about capital allocation toward new ventures amid tightening margins and the ongoing duty impacts on costs.

- **Strategic Priorities and Long-Term Vision**: Continued focus on expanding the Isostearic acid line was noted, with management expecting to capitalize on the demand for high-value specialty products in the downstream market.

5. **Market or Regulatory Updates**: The recent increase in customs duty on crude vegetable oils has led to rising raw material costs, impacting profit margins substantially. The company is hopeful for a possible reversal of these duties as market conditions evolve.

6. **Strategic Focus Areas**: There is a visible focus on developing high-margin specialty products, particularly Isostearic acid. The management displays confidence in regaining market share as demand from the paint sector may stabilize in the future.

7. **Investor Insight**: Given the company's current financial health, ongoing strategic initiatives in high-value products, and potential recovery in the paint sector demand, a hold position appears warranted. However, the impact of external regulatory and market challenges presents risks that could hinder short-term performance.